Serum levels of pregnancy zone protein are elevated in presymptomatic alzheimer's disease

Journal of Proteome Research

Volumn 10, Issue 11, 2011, Pages 4902-4910

  Ijsselstijn, Linda ^a   Dekker, Lennard J M ^a   Stingl, Christoph ^a   Van Der Weiden, Marcel M ^a   Hofman, Albert ^a   Kros, Johan M ^a   Koudstaal, Peter J ^a   Sillevis Smitt, Peter A E ^a   Ikram, M Arfan ^a   Breteler, Monique M B ^a   Luider, Theo M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; disease related marker; pregnancy zone protein; presymptomatic; proteomics; serum

Indexed keywords

PREGNANCY ASSOCIATED ALPHA2 GLYCOPROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MICROGLIA; NUCLEOTIDE SEQUENCE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANTHRACENES; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; BRAIN; CASE-CONTROL STUDIES; COHORT STUDIES; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PREGNANCY PROTEINS; PROSPECTIVE STUDIES;

EID: 80655126739     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200270z     Document Type: Article

References (33)

1. Prince, M.; Jackson, J. World Alzheimer Report; 2009.
2. Braak, H.; Braak, E. Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. 1991, 82 (4) 239-59
3. Neugroschl, J.; Sano, M. Current treatment and recent clinical research in Alzheimer's disease Mt. Sinai J. Med. 2010, 77 (1) 3-16
4. Cutler, P.; Akuffo, E. L.; Bodnar, W. M.; Briggs, D. M.; Davis, J. B.; Debouck, C. M.; Fox, S. M.; Gibson, R. A.; Gormley, D. A.; Holbrook, J. D.; Hunter, A. J.; Kinsey, E. E.; Pripffial, R.; Richardson, J. C.; Roses, A. D.; Smith, M. A.; Sokanas, N.; Wille, D. R.; Wu, W.; Yates, J. W.; Gloger, I. S. Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma Proteomics Clin. Appl. 2008, 2 (4) 467-77 (Pubitemid 351566256)
5. German, D. C.; Gurnani, P.; Nandi, A.; Garner, H. R.; Fisher, W.; Diaz-Arrastia, R.; O'Suilleabhain, P.; Rosenblatt, K. P. Serum biomarkers for Alzheimer's disease: proteomic discovery Biomed. Pharmacother. 2007, 61 (7) 383-9 (Pubitemid 47239345)
6. Guntert, A.; Campbell, J.; Saleem, M.; O'Brien, D. P.; Thompson, A. J.; Byers, H. L.; Ward, M. A.; Lovestone, S. Plasma gelsolin is decreased and correlates with rate of decline in Alzheimer's disease J. Alzheimers Dis. 2010, 21 (2) 585-96
7. Hye, A.; Lynham, S.; Thambisetty, M.; Causevic, M.; Campbell, J.; Byers, H. L.; Hooper, C.; Rijsdijk, F.; Tabrizi, S. J.; Banner, S.; Shaw, C. E.; Foy, C.; Poppe, M.; Archer, N.; Hamilton, G.; Powell, J.; Brown, R. G.; Sham, P.; Ward, M.; Lovestone, S. Proteome-based plasma biomarkers for Alzheimer's disease Brain 2006, 129 (Pt 11) 3042-50 (Pubitemid 44684524)
8. Liao, P. C.; Yu, L.; Kuo, C. C.; Lin, C. J.; Kuo, Y. M. Proteomics analysis of plasma for potential biomarkers in the diagnosis of Alzheimer's disease Proteomics Clin. Appl. 2007, 1 (5) 506-12
9. Liu, H. C.; Hu, C. J.; Chang, J. G.; Sung, S. M.; Lee, L. S.; Yuan, R. Y.; Leu, S. J. Proteomic identification of lower apolipoprotein A-I in Alzheimer's disease Dement. Geriatr. Cogn. Disord. 2006, 21 (3) 155-61
10. Thambisetty, M.; Simmons, A.; Velayudhan, L.; Hye, A.; Campbell, J.; Zhang, Y.; Wahlund, L. O.; Westman, E.; Kinsey, A.; Guntert, A.; Proitsi, P.; Powell, J.; Causevic, M.; Killick, R.; Lunnon, K.; Lynham, S.; Broadstock, M.; Choudhry, F.; Howlett, D. R.; Williams, R. J.; Sharp, S. I.; Mitchelmore, C.; Tunnard, C.; Leung, R.; Foy, C.; O'Brien, D.; Breen, G.; Furney, S. J.; Ward, M.; Kloszewska, I.; Mecocci, P.; Soininen, H.; Tsolaki, M.; Vellas, B.; Hodges, A.; Murphy, D. G.; Parkins, S.; Richardson, J. C.; Resnick, S. M.; Ferrucci, L.; Wong, D. F.; Zhou, Y.; Muehlboeck, S.; Evans, A.; Francis, P. T.; Spenger, C.; Lovestone, S. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease Arch. Gen. Psychiatry 2010, 67 (7) 739-48
11. Zhang, R.; Barker, L.; Pinchev, D.; Marshall, J.; Rasamoelisolo, M.; Smith, C.; Kupchak, P.; Kireeva, I.; Ingratta, L.; Jackowski, G. Mining biomarkers in human sera using proteomic tools Proteomics 2004, 4 (1) 244-56 (Pubitemid 38140889)
12. Akuffo, E. L.; Davis, J. B.; Fox, S. M.; Gloger, I. S.; Hosford, D.; Kinsey, E. E.; Jones, N. A.; Nock, C. M.; Roses, A. D.; Saunders, A. M.; Skehel, J. M.; Smith, M. A.; Cutler, P. The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone Biomarkers 2008, 13 (6) 618-36
13. Craig-Schapiro, R.; Perrin, R. J.; Roe, C. M.; Xiong, C.; Carter, D.; Cairns, N. J.; Mintun, M. A.; Peskind, E. R.; Li, G.; Galasko, D. R.; Clark, C. M.; Quinn, J. F.; D'Angelo, G.; Malone, J. P.; Townsend, R. R.; Morris, J. C.; Fagan, A. M.; Holtzman, D. M. YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease Biol. Psychiatry 2010, 68 (10) 903-12
14. Ghidoni, R.; Benussi, L.; Glionna, M.; Desenzani, S.; Albertini, V.; Levy, E.; Emanuele, E.; Binetti, G. Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cognitive impairment J. Alzheimers Dis. 2010, 22 (3) 985-91
15. IJsselstijn, L.; Dekker, L. J.; Koudstaal, P. J.; Hofman, A.; Sillevis Smitt, P.; Breteler, M. M.; Luider, T. Serum clusterin levels are not increased in presymptomatic Alzheimer's disease J. Proteome Res. 2011, 10 (4) 2006-10
16. Hofman, A.; Breteler, M. M.; van Duijn, C. M.; Janssen, H. L.; Krestin, G. P.; Kuipers, E. J.; Stricker, B. H.; Tiemeier, H.; Uitterlinden, A. G.; Vingerling, J. R.; Witteman, J. C. The Rotterdam Study: 2010 objectives and design update Eur. J. Epidemiol. 2009, 24 (9) 553-72
17. Breteler, M. M. Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study Ann. N.Y. Acad. Sci. 2000, 903, 457-65 (Pubitemid 30251589)
18. Slooter, A. J.; Cruts, M.; Kalmijn, S.; Hofman, A.; Breteler, M. M.; Van Broeckhoven, C.; van Duijn, C. M. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study Arch. Neurol. 1998, 55 (7) 964-8 (Pubitemid 28335115)
19. Prins, N. D.; van Dijk, E. J.; den Heijer, T.; Vermeer, S. E.; Koudstaal, P. J.; Oudkerk, M.; Hofman, A.; Breteler, M. M. Cerebral white matter lesions and the risk of dementia Arch. Neurol. 2004, 61 (10) 1531-4 (Pubitemid 39350263)
20. Progenesis LC-MS; version 2.5; Nonlinear Dynamics Ltd.: New Castle, U.K., 2009; http://www.nonlinear.com.
21. MacLean, B.; Tomazela, D. M.; Shulman, N.; Chambers, M.; Finney, G. L.; Frewen, B.; Kern, R.; Tabb, D. L.; Liebler, D. C.; MacCoss, M. J. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments Bioinformatics 2010, 26 (7) 966-8
22. Folkersen, J.; Teisner, B.; Grunnet, N.; Grudzinskas, J. G.; Westergaard, J. G.; Hindersson, P. Circulating levels of pregnancy zone protein: normal range and the influence of age and gender Clin. Chim. Acta 1981, 110 (2-3) 139-45 (Pubitemid 11102557)
23. Ekelund, L.; Laurell, C. B. The pregnancy zone protein response during gestation: a metabolic challenge Scand. J. Clin. Lab. Invest. 1994, 54 (8) 623-9 (Pubitemid 24380772)
24. Beckman, L.; von Schoultz, B.; Stigbrand, T. Pregnancy zone protein in sera from patients with prostatic cancer treated with oestrogens Urol. Res. 1973, 1 (2) 67-9
25. Chiabrando, G. A.; Sanchez, M. C.; Skornicka, E. L.; Koo, P. H. Low-density lipoprotein receptor-related protein mediates in PC12 cell cultures the inhibition of nerve growth factor-promoted neurite outgrowth by pregnancy zone protein and alpha2-macroglobulin J. Neurosci. Res. 2002, 70 (1) 57-64
26. Devriendt, K.; Van den Berghe, H.; Cassiman, J. J.; Marynen, P. Primary structure of pregnancy zone protein. Molecular cloning of a full-length PZP cDNA clone by the polymerase chain reaction Biochim. Biophys. Acta 1991, 1088 (1) 95-103
27. Chiabrando, G. A.; Vides, M. A.; Sanchez, M. C. Differential binding properties of human pregnancy zone protein- and alpha2-macroglobulin-proteinase complexes to low-density lipoprotein receptor-related protein Arch. Biochem. Biophys. 2002, 398 (1) 73-8 (Pubitemid 34848326)
28. Kovacs, D. M. alpha2-macroglobulin in late-onset Alzheimer's disease Exp. Gerontol. 2000, 35 (4) 473-9
29. Van Uden, E.; Sagara, Y.; Van Uden, J.; Orlando, R.; Mallory, M.; Rockenstein, E.; Masliah, E. A protective role of the low density lipoprotein receptor-related protein against amyloid beta-protein toxicity J. Biol. Chem. 2000, 275 (39) 30525-30
30. Van Uden, E.; Kang, D. E.; Koo, E. H.; Masliah, E. LDL receptor-related protein (LRP) in Alzheimer's disease: towards a unified theory of pathogenesis Microsc. Res. Tech. 2000, 50 (4) 268-72 (Pubitemid 30651164)
31. Sanchez, M. C.; Chiabrando, G. A.; Vides, M. A. Pregnancy zone protein-tissue-type plasminogen activator complexes bind to low-density lipoprotein receptor-related protein (LRP) Arch. Biochem. Biophys. 2001, 389 (2) 218-22 (Pubitemid 32881947)
32. Raber, J.; Huang, Y. D.; Ashford, J. W. ApoE genotype accounts for the vast majority of AD risk and AD pathology Neurobiol. Aging 2004, 25 (5) 641-50 (Pubitemid 38686487)
33. Saunders, A. M.; Strittmatter, W. J.; Schmechel, D.; Georgehyslop, P. H. S.; Pericakvance, M. A.; Joo, S. H.; Rosi, B. L.; Gusella, J. F.; Crappermaclachlan, D. R.; Alberts, M. J.; Hulette, C.; Crain, B.; Goldgaber, D.; Roses, A. D. Association of apolipoprotein-E allele epsilon-4 with late-onset familial and sporadic Alzheimers-disease Neurology 1993, 43 (8) 1467-72 (Pubitemid 23230526)